MRSA and Nursing homes: Is there a problem and do we need to change our guidelines?

Similar documents
MRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke

MRSA. Information for patients Infection Prevention and Control. Large Print

infection control MRSA Information for patients (Methicillin Resistant Staphylococcus aureus)

MRSA. Information for patients Infection Prevention and Control

Methicillin Resistant Staphylococcus aureus (MRSA) Procedure

Methicillin Resistant Staphylococcus aureus (MRSA) screening and decolonisation

Quality indicators for infection prevention and control in Belgian hospitals and public disclosure

Infection Prevention Control Team

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

MRSA: Help us to help to help you

Community Infection Prevention and Control Guidance for Health and Social Care

Skin and Nasal Decolonization for Adult

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION

THE SECRETS OF MRSA CONTROL IN THE NETHERLANDS. Margreet C. Vos Medical Microbiology and Infectious Diseases Erasmus MC, Rotterdam, the Netherlands

Reducing the risk of healthcare associated infection

Community Infection Prevention and Control Guidance for Health and Social Care

Reducing the risk of healthcare associated infection

A guide for patients and visitors MRSA. A guide for patients and visitors

Approval Signature: Date of Approval: December 6, 2007 Review Date:

Protocol for the Prevention and Management of Clostridium difficile.

Patient Information Service. Infection prevention and control department MRSA

Models for the organisation of hospital infection control and prevention programmes B. Gordts

Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection.

Hereford Hospitals NHS Trust

Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA

National Hand Hygiene NHS Campaign

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England

National Hand Hygiene NHS Campaign

Direct cause of 5,000 deaths per year

MRSA Meticillin-resistant

INFECTION CONTROL TRAINING CENTERS

HCAI Local implementation team action plan

Healthcare Acquired Infections

Disclosure Status (B) B Can be disclosed to patients and the public

Everyone Involved in providing healthcare should adhere to the principals of infection control.

Burden of MRSA Colonization in Elderly Residents of Nursing Homes: A Systematic Review and Meta Analysis

IC CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017

Systems to evaluate environmental cleanliness

Patient Information Service. Infection prevention and control department MRSA

BEHAVIORAL HEALTH & LTC. Mary Ann Kellar, RN, MA, CHES, IC March 2011

Checklists for Preventing and Controlling

(MRSA) De-isolation Procedure

Health Professionals (NMAHPs) Lanarkshire Infection Control Committee (LICC) Emer Shepherd, Head of Infection Prevention and Control

The Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA

& PVL Staphylococcus aureus (PVL-SA) Policy

Take Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home

1/28/2014. Take Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home. Thank you to AANAC

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT

Document Title: MRSA Policy. Document No. EDRMS000061C Version No. 1.0 replaces version 6. Approved by Clinical PAG Date approved 21/09/2012

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of

National Hand Hygiene NHS Campaign

Trust Policy, Infection Control

Infection Prevention and Control Strategy (NHSCT/11/379)

For further information please contact: Health Information and Quality Authority

POLICIES & PROCEDURES. Number: Authorization: SHR Regional Infection Control Committee

Prevention and control of healthcare-associated infections

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors

Antibiotic Use and Resistance in Nursing Homes

Self-Instructional Packet (SIP)

Infection prevention & control

Provincial Surveillance

Healthcare associated infections across the health and social care community

Running head: THERAPEUTIC NURSING 1

Prevalence survey of Healthcare Associated Infections and Antimicrobial Use in long term care facilities (HALT) Northern Ireland 2013.

Self-Assessment Summary Report 2017 Accreditation

METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION

Establishing an infection control accreditation programme to control infection

Policy for the control and management of patients colonised or infected with Meticillin Resistant Staphylococcus aureus (MRSA)

INFECTION CONTROL SURVEILLANCE POLICY

MRSA Management of patients with meticillin-resistant staphylococcus aureus. Ref IPC v3. Status: Approved Document type: Procedure

Investigating Clostridium difficile Infections

Clinical Research in Antibiotic Resistance

Infection Prevention. & Control. Report

Presented by: Mary McGoldrick, MS, RN, CRNI

Guideline with MDRO or C-Diff Patient Age Group: ( ) N/A (x ) All Ages ( ) Newborns ( ) Pediatric ( ) Adult

Patient Experience of Care Survey Results Hospital Consumer Assessment of Healthcare Providers and Systems (Inpatient)

The Management of Patients with Meticillin Resistant Staphylococcus Aureus Policy (MRSA)

Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8

The Physician's Role in Controlling MRSA in Healthcare Settings

Methicillin-Resistant Staphylococcus aureus Health and Social Care Act 2010 Contributes to CQC Core Standard Outcome 8

MMI 408 Spring 2011 Group 1 John Wong. Statement of Work for Infection Control Systems

TRUST BOARD. Date of Meeting: 05/10/2010

Joint Commission NPSG 7: 2011 Update and 2012 Preview

METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION

Patient and Visitor Involvement: The Hand Hygiene Missing Link?

Lightning Overview: Infection Control

Policy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019

ISOLATION PRECAUTIONS INTRODUCTION. Standard Precautions are used for all patient care situations, but they

Open and Honest Care in your Local Hospital

Infection Control and Prevention On-site Review Tool Hospitals

Staphylococcus aureus bacteraemia in Australian public hospitals Australian hospital statistics

Assisting with the Bedside (Percutaneous) Removal of Chronic Peritoneal Dialysis Catheters

How to Add an Annual Facility Survey

The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA)

Embedding a hospital-wide culture of infection control to reduce MRSA bacteraemia rates

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36

Job Title 22 February 2013

Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative

Transcription:

MRSA and Nursing homes: Is there a problem and do we need to change our guidelines? Dr. C. SUETENS, B. JANS, Scientific Institute of Public Health, Epidemiology, Dr. O. DENIS, Prof. M. STRUELENS, National MRSA reference laboratory, ULB, Brussels, BELGIUM IPH Epidemiology 1

With the support of the federal platform for hospital hygiene Belgian Antibiotic Policy Coordination Committee Belgian Infection Control Society

Situation in Belgian acute care hospitals National Campaign: Antibiotic Consumption - 2000 2004 and 2006 GUIDELINES (hospitals): 1993 AB policy steering committee in the hospitals -2002 2003: Revision GUIDELINES (Hosp.) Hand hygiene campaigns Antibiotic prophylaxis in surgery: 1997 MRSA / SA (%). 35 30 25 20 15 10 5 0 % MRSA+ at admission NH = reservoirs?? 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 MRSA / 1000 admissions. 1994/2 1995/1 1995/2 1996/1 1996/2 1997/1 1997/2 1998/1 1998/2 1999/1 1999/2 2000/1 2000/2 2001/1 2001/2 2002/1 2002/2 2003/1 2003/2 2004/1 2004/2 2005/1 2005/2 Resistance rate Study periods Incidence of nosocomial MRSA 3

1 st national prevalence study on MRSA-carriage in NH 2005 Methodology List of INAMI/RIZIV = 985 major care NH At random: region & proportion of major care beds Namur Limb. Br. Wal. Luxemb. Antw. Vl. Br. Br. Wal. Limb Ṇamur Br. Fl. Luxemb. Antw. O.-Vl. Brux. O.-Vl. Brussel Liège Hain. W.-Vl. Liège Hain. W.-Vl. Obj.. 1: prevalence MRSA-carriage in Belgian NH? Sampling: nose, throath & wound, urinary meatus Obj.. 2: determinants of MRSA-carriage at resident and institutional level? (questionnaire) Obj.. 3: molecular epidemiology and AB-resistance n= 60 NH 50 residents/ NH 4

Characteristics of participating NH Sample Number of participating NH: 60 (6.1%) 985 BELGIUM Screened residents (max.50/nh): 2958/6365 94.515 Distribution of the NH by region: (46% of the sample) Flanders 36 (60%) 586 (59%) Walloon 18 (30%) 304 (31%) Brussels 6 (10%) 95 (10%) Ownership: Private 41 (68%) 624 (63%) Mean % major care beds: 46% (15-97%) 49% Mean number beds/nh: 106 (38-279 beds) 96 Fl: 109 W: 87 BR: 144 (p=0.047) Private: 104 Public: 111 (n.s.).) 5

Prevalence of S. aureus and MRSA Total number of screened residents: 2953 Weigthed mean MRSA-prevalence: 19% [CI 95% 17-22] (min. 2% - max. 43%) S. aureus negative culture n =1453 49% MRSA n = 587 Weighted mean resistance proportion: 38% [CI 95% 33-42] (min. 4% - max. 75%) MSSA n = 913 S. aureus prevalence: 51% (min. 22% - max. 70%) S. aureus positive culture n =1500 6

Distribution of MRSA-carriage prevalence rates in NH (% MRSA/residents residents) 50 Q. 25 Median Q. 75 40 Weigthed mean MRSA-prevalence: 19% 30 20 10 2000 (n=24 NH): 4.7% 0 7 23 53 24 30 12 1 37 32 59 29 7 34 31 49 50 60 2 58 33 22 56 25 26 55 41 44 45 139 21 19 4 28 39 14 438 10 54 3 57 38 27 36 18 11 42 5 52 16 20 35 17 46 51 47 48 40 15 6 participating NH % MRSA carriers/nh

MRSA prevalence by region p=0,13 MRSA carriage % 0 10 20 30 40 18.1% [IC95% 15-21.3] 22.2% [IC95% 17.2-27.4] 17.2% [IC95% 13.4-21] Vlaanderen Brussels W allonie 8

How frequent are infections in NH s*? At least 1 outbreak during last year 22 Type of outbreaks Gastro-enteritis Clostridium difficile MRSA % 59 18 6 Clostridium difficile strains in hospitals % coming from NH-residents 20 MRSA-carriage among NH-residents 19 Is MRSA problematic in your NH? Yes No Don t t know, no answer 55 13 32. Underestimation of infectious problems in some NH. 56% of NH never take screening samples * source: coordinating physician and nursing responsible %MRSA 19 15 24 9

Coordination of medical and nursing care in the NH In Major care NH: 1 Coordinating physician (RD 24/6/1999) coordination of medical activities, healthcare problems potentially dangerous for residents/staff and 31 GP / NH (min. 3 - max. 96) 1 GP / 4.4 beds (min. 1/1.4 max. 1/36.7) GP/beds ratio % mean MRSA% MRSA > 19%. 1 GP/ < 4 beds 63.3 21.9 63.2 1 GP/ 4 beds and + 36.7 16.2 31.8 OR: 3.67 [1.05-13.26], p=0.02 AB-policy in the NH Yes (%) % MRSA. Use mupirocine for decolonisation of wounds 71 21 15 Creation formulary with GP s = CP task 58 19 20 GP aggreements AB use = task CP 32 22 19 Formulary used<> not used/ not available 29 15 22 Aggreements about AB-prescription 18 18 20 Written aggreements: AB-use 13 19 20 Limitation AB choice for prescription 7 16 10 20 Free use AB-ointments for wound care by nurse 3 29 20

Hand hygiene 1 - Available products Yes MRSA% Availability of products for hand hygiene % Yes No Liquid soap 98 20 13 Hydro-alcoholic lotion or gel 84 20 20 Antiseptic soap 75 20 18 Bar solid soap 4 25 20 Type of towels. Single use or electric 90 19 22 2 Use of gloves Indications for glove use. Residents with fecal incontinence 85 18 27 Wound care 77 19 22 Care urinary catheter 67 19 20 Desinfection of materiel 62 20 20 Gastrostomy 54 18 21 Residents with urinary incontinence 51 19 20 Residents with flu 34 15 22 NOTE: no hand hygiene after removing gloves = 8% 11

Management of MRSA-carriers 1 Room arrangements for MRSA carriers Yes MRSA% Proportion of single rooms % Yes No. All NH-rooms are single 13 18 20 Room arrangements for carriers. Isolation in single room 79 19 25 Cohorting carriers 54 20 20 Cohort nursing 32 18 21 2 - Additional precautions Additional precautions. Gloves 98 20 3 Mask 86 20 18 Apron 90 20 20 Reinforced cleaning (room) 92 20 18 3 Written care protocols Availability of written care protocols. Protocol for management of MRSA-carriers 80 19 20 Isolation of contagious residents 54 17 22 Hygiene policy in the NH 47 20 12 19

Detection, eradication and follow-up Yes MRSA% 1 - Screening of reservoirs % Yes No. Residents after hospitalisation 44 18 22 Staff 22 19 20 2 - Decolonisation of carriers. Decolonisation of carriers 90 21 14 Control sample after decolonisation 97 20 14 Used decolonisation scheme (n=40). Nasal decolonisation only 28 18 Nasal decolonisation + antiseptic bath 43 22 Not conform decolonisation scheme (AB) 10 21 Other answer 20 19 3 Communication and collaboration. Always receive transfer document 68 19 22 Collaboration with experts. Advice regional platform Hospital hygiene 69 21 18 Collaboration with Hospital hygiene team 61 20 19 4 - Surveillance of MRSA. Yes 64 19 21 13

National recommendations for the prevention of transmission of methicillin resistant Staphylococcus aureus (MRSA) in Belgian Nursing Homes - June 2005-14

One year later, 84% of NH used guidelines for creation of indoor protocol Since the last year, adaptation of: Hand hygiene practice 91% Register of MRSA-carriers 80% Additional precautions (MRSA) 61% Screening practices 52% Decolonisation of carriers 48% AB-policy 25% To do: Improve communication and collaboration Install specific infection prevention structure in NH Perform training of all NH professionals Additional ressources 15